Drugmakers selected for "Operation Warp Speed," the White House's ambitious plan to develop a coronavirus vaccine in record time, will enjoy priority access to manufacturing capacity secured by the U.S. government, as well as to needed supplies like glass vials.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,